2015 Annual Meeting | Should All Brain Tumor Patients Receive Prophylactic Anti-Epileptic Drugs?
No timeline events available at this time. |
Howard Colman, MD, PhD, FAAN | No disclosure on file |
Nicole Ullrich, MD, PhD, MMSci, FAAN | Dr. Ullrich has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion Pharmaceuticals. The institution of Dr. Ullrich has received research support from Children's Tumor Foundation. Dr. Ullrich has received intellectual property interests from a discovery or technology relating to health care. Dr. Ullrich has received publishing royalties from a publication relating to health care. |